Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Journal of Visualized Experiments : Jove
|
January 13, 2025
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
Mary-Keara Boss, Braden Burdekin, Lauren Harrison, et al.
Pediatric Blood & Cancer
|
April 27, 2011
Health-related quality of life (HRQoL): the impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation
Lisa Brice, Rebecca Weiss, Ying Wei, et al.
Respiration; International Review of Thoracic Diseases
|
March 16, 2021
A Pilot Study of RNA Sequencing to Improve the Diagnostic Yield of Bronchoalveolar Lavage Specimens in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
Jeremy M Rosenblum, Nadav Traeger, John Welter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study
Mitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Eclinicalmedicine
|
July 11, 2025
Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial
Jessica Hochberg, Javier Oesterheld, Aliza Gardenswartz, et al.
British Journal of Haematology
|
April 19, 2011
Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report
Bruce Shiramizu, Stanton Goldman, Ian Kusao, et al.
Blood
|
November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
Mary Gerrard, Ian M Waxman, Richard Sposto, et al.
British Journal of Haematology
|
June 28, 2013
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report
Matthew J Barth, Stanton Goldman, Lynette Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962
Richard E Harris, Amanda M Termuhlen, Lynette M Smith, et al.
Journal for Immunotherapy of Cancer
|
May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial
Jessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Journal of Visualized Experiments : Jove
|
January 13, 2025
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
Mary-Keara Boss, Braden Burdekin, Lauren Harrison, et al.
Pediatric Blood & Cancer
|
April 27, 2011
Health-related quality of life (HRQoL): the impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation
Lisa Brice, Rebecca Weiss, Ying Wei, et al.
Respiration; International Review of Thoracic Diseases
|
March 16, 2021
A Pilot Study of RNA Sequencing to Improve the Diagnostic Yield of Bronchoalveolar Lavage Specimens in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
Jeremy M Rosenblum, Nadav Traeger, John Welter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study
Mitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Eclinicalmedicine
|
July 11, 2025
Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial
Jessica Hochberg, Javier Oesterheld, Aliza Gardenswartz, et al.
British Journal of Haematology
|
April 19, 2011
Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report
Bruce Shiramizu, Stanton Goldman, Ian Kusao, et al.
Blood
|
November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
Mary Gerrard, Ian M Waxman, Richard Sposto, et al.
British Journal of Haematology
|
June 28, 2013
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report
Matthew J Barth, Stanton Goldman, Lynette Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962
Richard E Harris, Amanda M Termuhlen, Lynette M Smith, et al.
Journal for Immunotherapy of Cancer
|
May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial
Jessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Page
of 5